Clinical Trial

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Name: A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis — clinical trial record (NCT06660992)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a phase III, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.

Trial Details

NCT Number	NCT06660992
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Non-cystic Fibrosis Bronchiectasis
Enrollment	669 participants
Start Date	2024-09-30
Primary Completion	2026-11-28 (estimated)
Study Completion	2027-01-27 (estimated)
Updated on ClinicalTrials.gov	2024-10-28